Since 1999, Syntermed, Inc., a privately-held nuclear medicine imaging and informatics software company based in Atlanta, GA, has served cardiology, nuclear medicine and radiology labs worldwide through all major OEM imaging providers and leading value-added resellers, as well as, direct. The Founders have over 75 years of combined experience in the development and commercialization of medical imaging software. Syntermed software quantifies and delivers decision support for the analysis of SPECT, PET, and CT images of the heart and brain. Emory Toolbox™ AI, now in its fourth generation, is one of the most widely applied methods of cardiac imaging, used in labs worldwide. Version 4 is distinguished as the first Nuclear Cardiology AI platform to receive FDA 510K clearance, ISO certification and carry a CE mark. NeuroQ™ is one of the most widely utilized software solutions for the quantification of brain studies with PET-FDG, Amyloid, Spect, DaTscan and Epilepsy. Syntermed Live™, which currently hosts almost 1M studies, is a cloud-based and HIPAA compliant platform used by nuclear medicine physicians to get round-the-clock secure, remote access to their studies and reports no matter where they are. All of Syntermed’s software is compatible with virtually any nuclear medicine workstation or PC/MAC that supports Microsoft® Windows® operating system.

who is syntermed?

OUR TEAM

Syntermed has executive and technical teams with the right balance of experience in the medical and software fields.

Earnest V. Garcia, PhD

Ken Van Train

Michael Lee

Chairman and CEO

President

Chief Scientific Advisor

Kelly Champagne, PhD

C. David Cooke

Paulo Cardona

Senior Software Applications Engineer

Director of Clinical Applications

Director of Contracts and Grants
Asst. Regulatory Officer
Applications Testing

Jennifer Miller

Ron Fuller

Richard Eppes

Director of Technology

Senior Application Support Manager

Senior Applications and Business Development Manager

Chief Scientific Advisor

Earnest V. Garcia, PhD

President

Ken Van Train

Chairman and CEO

Michael Lee

Director of Contracts and Grants
Asst. Regulatory Officer
Applications Testing

Kelly Champagne, PhD

Director of Clinical Applications

C. David Cooke

Senior Software Applications Engineer

Paulo Cardona

Senior Applications and Business Development Manager

Jennifer Miller

Senior Application Support Manager

Ron Fuller

Director of Technology

Richard Eppes

About Michael Lee

MICHAEL LEE

Chairman and CEO

Ken van train

President

About Ken Van Train

About Earnest V. Garcia, PhD

Earnest V. Garcia, PhD

Chief scientific advisor

About Paulo Cardona

Paulo cardona

senior software applications engineer

About David Cooke

c. david cooke

director of clinical applications

About Kelly Champagne

kelly champagne, phd

director of contracts and grants
Assistant regulatory officer
applications testing

About Richard Eppes

Richard Eppes

director of technology

About Ron Fuller

Ron fuller

senior application support manager

About Jennifer Miller

jennifer miller

Senior applications and business development manager

As chairman and chief executive officer for Syntermed, Lee is part of the executive team which oversees Syntermed’s product and business strategy as well as the company's daily operations including business development, finances, sales, marketing, professional services and administration. Lee is also a member of Syntermed’s Board of Directors. With over 40 years of technology and leadership experience, Lee has a strong track record in building teams for marketing, sales, business development, software engineering and has managed all phases of the software business. Lee served as Vice President for Sales and Business Development, eMarketing for Mobular Technologies where he was part of a team which secured a round of Series A funding. Prior to joining Mobular, Lee was National Sales Director for Commercial Software Products for MessageMedia, Inc. (SoftBank portfolio company acquired by DoubleClick), where he managed a team which grew revenue 300% in just one year. Lee joined Messagemedia when it acquired Revnet Systems, Inc, an early leader in the Internet direct e-mail marketing software segment. Earlier, Lee spent several years at Georgia Tech. First as Director of Sales and Marketing for the Computer-Aided Structural Engineering Center at the Georgia Institute of Technology where he also spent several years developing large scale engineering software solutions, and then later as Manager of Intellectual Property Marketing for the Georgia Tech Research Corporation where he worked with the Advanced Technology Development Center and other Atlanta entrepreneurs to transfer technology from Georgia Tech to the commercial sector. Lee earned both a Masters and Bachelors degree in Structural Engineering with Highest Honor from Georgia Tech and is a member of the Technology Association of Georgia (TAG), the Atlanta CEO forum, a past director of the Atlanta chapter of the American Lung Association, and was a charter member of the Atlanta Peachtree Rotary Club.

MICHAEL LEE

Chairman and CEO

Since its inception, Ken Van Train has been the President of Syntermed spearheading the software validation, regulation, and commercialization of Emory Toolbox™ and NeuroQ™ and related medical imaging software applications. A primary responsibility includes the oversight for quality control, customer service and training. Most recently, Van Train was principal Investigator for two NIH Small Business grants (STTR and SBIR) through Syntermed totaling over $3.3 million in funding. His FDA medical device regulatory experience is extensive. Collectively Van Train has guided 22 pre-market notification 510k submissions for Syntermed and other nuclear medicine device companies, all of which have been accepted by the FDA. In in 2018 he successfully applied for and obtained ISO 13485:2016 certification (Certificate 670241) in the EU and in 2019 obtained the CE Mark for the Emory Toolbox™ and NeuroQ™ (CE 696491). For more than two decades he served as director of computer research and development at the department of medical physics and imaging, Cedars-Sinai Medical Center. He also served as the president of NucCardiac Software, Inc., a medical device software company for 15 years. While at Cedars-Sinai Medical Center, Van Train was a co-investigator involved with the development, validation, and commercialization of four medical software products: Cedars Planar Quantitative Tl-201, Cedars Quantitative SPECT TL-201, Cedars-Emory CEqual®, and the Emory Cardiac Toolbox. He has authored or co-authored 77 manuscripts and book chapters and 152 abstracts in the field of nuclear medicine and image processing. Ken Van Train received his Masters in Computer Science from Azusa Pacific University in 1996 and holds a Bachelor of Science degree in Biology from Loyola Marymount University, class of 1972.

ken van train

President

Earnest V. Garcia, PhD

Chief scientific advisor

Endowed Professor in Cardiac Imaging, Department of Radiology and Imaging Sciences, Emory University School of Medicine
B.S. 1971, M.S., 1972, Ph.D. 1974, Physics, University of Miami

Dr. Garcia is an Endowed Professor in Cardiac Imaging in the Department of Radiology and Imaging Sciences at Emory and a full time researcher. His main area of research has been in the field of quantitative analysis of cardiac images. His techniques have resulted in six commercial products used worldwide for quantifying myocardial perfusion images. He is a member of the editorial boards of six journals. Dr. Garcia is a past President of the Cardiovascular Council of the Society of Nuclear Medicine, the 1996/97 President of the Institute for Clinical PET, the 2002-03 President of the American Society for Nuclear Cardiology and the 2003-04 Founding President of the American Society for Nuclear Cardiology Foundation. In 2006 and 2007 he was selected by the readers of Medical Imaging Magazine as a Medical Imaging Industry Top 10 Nuclear Medicine Researcher. Designated by the Better World Project for his leadership role in starting a successful company, spun off from academic research that has changed the world. Named Game Changer by Emory University School of Medicine for his role in the development of tools for the objectification of image interpretation. Named to the Council of Distinguished Investigators of the Academy of Radiology Research. His biography has been featured in the History Corner of the J. Nucl. Cardiol. 27, 1919–1922 (2020). He is a co-author of > 360 peer reviewed articles, 60 book chapters and co-editor of 10 books. 

Paulo Cardona

senior software applications engineer

Support software development team with application programming tasks mainly within a Microsoft environment. Roles and responsibilities shall include but not be limited to software/application testing, high level technical user support of applications, and creation of documentation, both inline and related to testing and compliance for owned code and features.

Mr. Cooke has been with Syntermed since 2004, where he is currently serving as the Director of Clinical Applications. In this role he is responsible for developing, defining and driving clinical application strategies. He also works part-time for the Emory University Nuclear Cardiology R&D laboratory; a position he has held for over 30 years. He has served as one of the main software developers for both NeuroQ and the Emory Cardiac Toolbox, and has worked on all aspects of the design and development of both applications. He also has extensive experience in working with 3rd party vendors to successfully deploy both clinical applications to end users. His dual positions at Syntermed and Emory give him the unique and invaluable opportunity of seeing and experiencing both the academic and commercial side of software design, development and deployment. Mr. Cooke received his Master of Science in Electrical Engineering degree from the Georgia Institute of Technology in 1987, and has authored or co-authored 14 book chapters, 64 manuscripts and 109 abstracts.

C. David Cooke

Director of clinical applications

Dr. Champagne oversees the grant program at Syntermed. She successfully acquired four SBIR/STTR three multi-year grants totaling over $3.3 million. She coordinates all documentation related to SBIR/STTR grants submitted to the National Institute of Health (NIH), NSF and others. In addition, she handles accounting matters regarding SBIR and STTR grants.

In another capacity, Dr. Champagne works with senior management and business development to determine the strategy and functions of digital communications and coordinates implementation of these strategies, maintaining the website as well as coordinating tutorials and newsletters.  

In Dr. Chamagne's role as Administrative Assistant to the Regulatory Officer, she assists with product 510(k) and CE mark submissions, periodic updates, and registrations to regulatory agencies. This includes the organization of regulatory information, and track and control 510(k) submissions, assisting with the maintenance of QSR regulatory files/database, and assisting the Regulatory Officer with hosting regulatory compliance audits as required by agencies or partners.

Finally, Dr. Champagne is jointly responsible for the alpha and beta testing of applications before they are commercially released, which satisfies the regulatory compliance with the FDA and ISO certification for medical devices. In this capacity, she provides the testing required to insure that the applications are working as intended without errors.  

Kelly Champagne

Director of Contracts and Grants
Asst. Regulatory Officer, Applications Testing

As the Director of Technology, Richard is responsible for Syntermed's software development and IT infrastructure teams. Before his time at Syntermed, he managed systems development and infrastructure for The Birmingham News. He was technical lead on Toyota's new and used vehicle configuration web site and dealer facing tools. Richard managed large data conversions and search indexing products for Mobular Technologies. He was the architect of a remote, live video capture and management solution for Divine, Inc. Richard also previously worked on room audio systems at ASPI Digital (Atlanta Signal Processors Inc).

Richard has a degree from the Georgia Institute of Technology in Computer Engineering specializing in embedded systems and signal processing (DSP) and graduated from the co-op program.

Richard Eppes

director of technology

Working knowledge of Company software applications required. Participate in the implementation of marketing, sales, or training programs such as trade shows and webinars.

Ron Fuller's background involves working in imaging and interacting with patients and physicians as a nuclear technlogist for 8 years prior to becoming a Syntermed employee. His current role is application manager and in that capacity, he is responsible for coordinating all end-user and strategic partner pre and post sales application support remotely. He interacts with imaging professionals at hospitals and clinics to install and demonstrate the proper use of Syntermed's applications.

He is also jointly responsible for the alpha and beta testing of our applications before they are commercially released, which satisfies our regulatory compliance with the FDA and ISO certification for our medical devices. In this capacity, he provides the testing required to insure that the applications are working as intended without errors.  

Ron Fuller

Senior Application Support Manager

Ms. Miller worked as a nuclear medicine technologist for eight years. After leaving clinical practice, she has worked in the medical software field. In her role, Jennifer provides pre and post sales product support and installation coordination. In addition, she participates in implementing marketing, sales, and training programs.

Jennifer miller

Senior Applications and Business Development Manager

Terms of use & privacy policy

©2022 SYNTERMED INC. - ALL RIGHTS RESERVED. | FOR PERMISSION, EMAIL 

Emory Toolbox is a trademark of Emory University.    AdreView, Xeleris, DaTscan, Vizamyl and GE are trademarks of General Electric Company.
Amyvid is a trademark of Eli Lilly and Company.    NeuraCeq is a trademark of Piramal Imaging.    ImageGuide is a trademark of the American Society of Nuclear Cardiology.   
PYLARIFY AI is a Trademark of Lantheus Holdings, Inc.

Syntermed medical devices have received FDA (Quality System Records/Pre-Market Notfication) 510(k) clearance and European Union (ISO 13485:2016 FM 670241/CE Mark 696491) regulations. See eIFU for ECTb and NeuroQ.

Syntermed, Inc.
333 Sandy Springs Circle NE, Suite 107, Atlanta, GA 30328

TEL (888) 263-4446 | FAX (888) 216-7511

Privacy Notice    

HIPAA     

MSA